ATE445395T1 - Verfahren zur unterdrückung der ptx3 genexpression - Google Patents

Verfahren zur unterdrückung der ptx3 genexpression

Info

Publication number
ATE445395T1
ATE445395T1 AT03746454T AT03746454T ATE445395T1 AT E445395 T1 ATE445395 T1 AT E445395T1 AT 03746454 T AT03746454 T AT 03746454T AT 03746454 T AT03746454 T AT 03746454T AT E445395 T1 ATE445395 T1 AT E445395T1
Authority
AT
Austria
Prior art keywords
sup
sub
suppressing
gene expression
ptx
Prior art date
Application number
AT03746454T
Other languages
English (en)
Inventor
Shigeru Morikawa
Akashi Izumi
Takao Hamakubo
Tatsuhiko Kodama
Original Assignee
Kowa Co
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co, Nissan Chemical Ind Ltd filed Critical Kowa Co
Application granted granted Critical
Publication of ATE445395T1 publication Critical patent/ATE445395T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03746454T 2002-04-15 2003-04-11 Verfahren zur unterdrückung der ptx3 genexpression ATE445395T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37211402P 2002-04-15 2002-04-15
US10/196,428 US20030195167A1 (en) 2002-04-15 2002-07-17 PTX3-gene expression inhibitor
PCT/JP2003/004603 WO2003086380A1 (en) 2002-04-15 2003-04-11 Ptx3 gene expression suppressing method

Publications (1)

Publication Number Publication Date
ATE445395T1 true ATE445395T1 (de) 2009-10-15

Family

ID=28794074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03746454T ATE445395T1 (de) 2002-04-15 2003-04-11 Verfahren zur unterdrückung der ptx3 genexpression

Country Status (9)

Country Link
US (2) US20030195167A1 (de)
EP (1) EP1494661B1 (de)
JP (1) JP4409295B2 (de)
AT (1) ATE445395T1 (de)
AU (1) AU2003226456A1 (de)
DE (1) DE60329668D1 (de)
MY (1) MY137134A (de)
TW (1) TWI349547B (de)
WO (1) WO2003086380A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4719572B2 (ja) * 2003-04-17 2011-07-06 興和株式会社 Ｌｋｌｆ／ｋｌｆ２遺伝子発現促進剤
WO2005053683A1 (en) * 2003-11-26 2005-06-16 Duke University A method of preventing or treating glaucoma
ITRM20030596A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
WO2005080981A1 (ja) * 2004-02-25 2005-09-01 Perseus Proteomics Inc. 血管障害の程度の判定方法
BRPI0510245A (pt) * 2004-04-26 2007-10-23 Alcon Inc estatinas para o tratamento de hipertensão ocular e glaucoma
EP2033646A4 (de) * 2006-06-29 2009-11-18 Kowa Co Vorbeugender und/oder therapeutischer wirkstoff für rheumatoide arthritis
CN106950366B (zh) * 2017-02-15 2019-03-22 中国医学科学院北京协和医院 一种acpa阴性的ra诊断标志物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244916A (en) * 1992-01-31 1993-09-14 The Scripps Research Institute Inhibition of respiratory burst using posttranslational modification inhibitors
WO1999026657A1 (en) * 1997-11-25 1999-06-03 Musc Foundation For Research Development Inhibitors of nitric oxide synthase
EP1163203A1 (de) * 1999-03-08 2001-12-19 Merck & Co., Inc. Wasserhaltiges, kristallines calcium-salz der simvastatin dihydroxy offene säure
US6403637B1 (en) * 1999-08-09 2002-06-11 Univ Saint Louis Methods of modulating matrix metalloproteinase activity and uses thereof
CA2399396A1 (en) * 2000-02-10 2001-08-16 Yasuo Sugiyama Tnf- .alpha. inhibitors
WO2002024194A2 (en) * 2000-09-19 2002-03-28 Novimmune S.A. Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
US20020159974A1 (en) * 2000-09-19 2002-10-31 Francois Mach Treatment of multiple sclerosis with statins (HMG-CoA reductase inhibitors)

Also Published As

Publication number Publication date
MY137134A (en) 2008-12-31
TWI349547B (en) 2011-10-01
JP2005522490A (ja) 2005-07-28
DE60329668D1 (de) 2009-11-26
US20080161348A1 (en) 2008-07-03
AU2003226456A1 (en) 2003-10-27
EP1494661A1 (de) 2005-01-12
TW200403990A (en) 2004-03-16
AU2003226456A8 (en) 2003-10-27
WO2003086380A1 (en) 2003-10-23
JP4409295B2 (ja) 2010-02-03
EP1494661B1 (de) 2009-10-14
US20030195167A1 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
TW200519088A (en) Aryl or heteroaryl amide compounds
ATE302001T1 (de) Stabilisierte askorbinsäurederivate
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
NO20055337L (no) Imidazolinkorrosjonsinhibitorer
WO2005089256A3 (en) Antiangiogenic agents
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
ATE402185T1 (de) Verfahren für fluorcytidinderivate
ATE445395T1 (de) Verfahren zur unterdrückung der ptx3 genexpression
EP0879841A3 (de) Organosiliciumverbindung, Verfahren zur Herstellung dieser Verbindung und diese Verbindung enthaltende elektrolumineszente Vorrichtung
ATE207055T1 (de) Verfahren zur herstellung von 4-aryl-3- hydroxymethyl-piperidinen
EA200800149A1 (ru) 4,5-диарилпиррольные производные, способ их получения и применение в терапии
DK2000473T3 (da) Trehalose-forbindelse og lægemiddel omfattende forbindelsen
TW200505438A (en) Method of treating cancer with azaspirane compositions
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
EA200500716A1 (ru) Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат
DE60140333D1 (de) Lichtempfindliche Verbindung und lichtempfindliches Harz
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
RS20050937A (en) Resolution of alpha- (phenoxy)phenylacetic acid derivatives
SI1735274T1 (sl) Nepeptidni inhibitorji matriksnih metaloproteinaz
DK0504290T3 (da) Inhibitorer af dihydrofylatreduktase fra Pneumocystis carinii
ES2144327T3 (es) Procedimiento para preparar un compuesto de 2-cianobifenilo.
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
FR2826005B1 (fr) Synthese totale de la galanthamine, de ses analogues et de ses derives
TWI266770B (en) Polymer compound, positive resist composition and method for forming resist pattern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties